0KCS

OPKO Health, Inc.

Common Stock · USD · NASDAQ

OPKT212

Price

$1.41

+10.16%

Cap

$58.79B

Earnings

30d Trend

+15.6%

0KCS
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

41% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level65
Quality46
Momentum14
Technical60
Fundamentals50

Raw weighted: 38×Macro 0.99 (1%)=38

RISK

65/100
90d Volatility
40.9%High
ATR %
3.5%High daily moves
Max Drawdown (1Y)
-30.4%Volatile

QUALITY

46/100
ROE (avg)
-17.8%Negative
Piotroski F-Score
3/9Weak
Debt/Equity
0.27Low leverage
Accruals
-2.4%Cash earnings

MOMENTUM

14/100
12-1M Momentum
-23.7%Strong downtrend
6-1M Momentum
-23.7%Negative
1M Return
+28.8%Strong recent gains

TECHNICAL

60/100
RSI (14)
79.3Overbought
Price vs SMA200
+10.0%Bullish trend
MACD
+0.04Bullish momentum
Bollinger Band
122%Near upper band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.627Clean trend

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months77
3-12 months57
1-5+ years49

5-10 day swing — momentum continuation

BRAIN47'S ASSESSMENT

I rate OPKO Health, Inc. at 38/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 60/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+28.8%

3 MONTHS

+19.2%

12 MONTHS

+5.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

5-10 day swing — momentum continuation. Technical (60) and Fundamentals (50) are the primary strengths. I note that momentum is the weakest area at 14/100 — this warrants monitoring. Historical volatility is elevated at 41%. I classify this as a speculative position — elevated volatility at 41% and smaller market cap define the opportunity.

speculativeScore: 38/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.